|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52773485
???header.onlineuser??? :
543
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"wang hp"???jsp.browse.items-by-author.description???
Showing items 161-185 of 255 (11 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page
| 高雄醫學大學 |
2002 |
Volatile organic compound emissions during Cold-Starts of Motorcycle
|
Wang, HC;Wang, HP;Oeng, CY;劉慧俐 |
| 國立臺灣大學 |
2002 |
A multiple logistic regression analysis of risk factors in different subtypes of gastric ulcer
|
Chen, MH; Wu, MS; Lee, WC; Wang, HP; Lin, JT |
| 中國醫藥大學 |
2002 |
Inhibition of lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages by a synthetic carbazole, LCY-2-CHO
|
Tsao, LT; Lee, CY; Huang, LJ; Kuo, SC; Wang, HP |
| 臺北醫學大學 |
2001 |
Component analysis on black ant (Polyrhchis lamellidens) extracts from supercritical fluid extrction
|
王惠珀; Cheng YD; Tseng CH; Wang HP; Liao CC |
| 臺北醫學大學 |
2001 |
Optimization of drug in vivo activity via pharmacokinetic studies.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2001 |
用於治療巴金森氏症之新穎二及三胜 太仿擬化合物
|
王惠珀; Wang HP; Lee JS; Tsai MC; Lu HHHu OYP; Lo WL |
| 臺北醫學大學 |
2001 |
Optimization of drug in vivo activity via pharmacokinetic studies.
|
王惠珀; Wang HP |
| 國立臺灣大學 |
2000-12 |
Preparation and antitumor activities of beta-azatyrosinamides.
|
Wang, HP; Wu, MF; Shew, JY; Lee, O; Lee, SJ; Sung, CH. |
| 臺北醫學大學 |
2000 |
Neue Azatyrosin-Analogs and the process of preparation thereof.
|
王惠珀; Wang HP; Lee On; Shew JY; Lee SJ |
| 臺北醫學大學 |
2000 |
Preparation and antitumor activities of b-azatyrosinamides.
|
王惠珀; Wang HP; Wu MF; Shu CY; Lee O; Lee SJ; Sung CH |
| 臺北醫學大學 |
2000 |
D-Phenylglycine-L-dopa as slow-release prodrug of dopamine.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (I): Anti-Parkinsonism Effect of D-Phenylglycine-L-dopa and L-Dopa-D-Phenylglycine after Oral Administration.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Aminoacyl Antraquinones as potential antineoplastic agents.
|
王惠珀; Lee O; LeeLT; Wu HS; Wang HP |
| 臺北醫學大學 |
1999 |
Selective cytotoxicity of novel Azatyrosinamides.
|
王惠珀; Lee O; Li YI; Hwang CF; Wang HP |
| 臺北醫學大學 |
1999 |
b-Azatyrosinamides: Synthesis and Selective cytotoxicity
|
王惠珀; Lee O; Wang HP |
| 臺北醫學大學 |
1999 |
Synthesis and inhibition of pyrimidine analogues on bovine liver dihydrofolate redutase.
|
王惠珀; Lee O; Wu HS; Liu WC; Wang HP |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (II): CNS Bioavailability of D-Phenylglycine-L-dopa in Rats.
|
王惠珀; Lee SN; Wang HP |
| 臺北醫學大學 |
1999 |
Intestinal Oligopeptide Transporter (PepT1) as a Drug Delivery System: D-Phenylglycine as a Seeing-eye Dog for L-Dopa Transport through PepT1.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Selective cytotoxicity of novel Azatyrosinamides.
|
王惠珀; Lee O; Li YI; Hwang CF; Wang HP |
| 臺北醫學大學 |
1999 |
Synthesis and inhibition of pyrimidine analogues on bovine liver dihydrofolate redutase.
|
王惠珀; Lee O; Wu HS; Liu WC; Wang HP |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (III): Species Differences between Rats and Rabbits in the Pharmacokinetics of D-Phenylglycine-L-dopa.
|
王惠珀; Luo WW; Fan YB; Wang HP; |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (II): Species Differences between Rats and Rabbits in the Pharmacokinetics of D-Phenylglycine-L-dopa.
|
王惠珀; Luo WW; Fan YB; Wang HP; |
| 臺北醫學大學 |
1999 |
Intestinal Oligopeptide Transporter (PepT1) as a Drug Delivery System: D-Phenylglycine as a Seeing-eye Dog for L-Dopa Transport through PepT1.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Primary sclerosing cholangitis in a child.
|
朱娟秀; Lin WT; Lin SJ; Ni YH; Chen HL; Wang HP; Chu JS; Chang MH; |
| 臺北醫學大學 |
1998 |
Methods in the Preparation of D-Phenylglycine-containing Cefotaxime Double Esters (Cefotaxime-PG).
|
王惠珀; Sun CH; Wang HP |
Showing items 161-185 of 255 (11 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page
|
